SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 72 filers reported holding SOLID BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,700,000 | -24.2% | 7,929,918 | 0.0% | 0.44% | -22.9% |
Q2 2022 | $4,882,000 | -48.7% | 7,929,918 | 0.0% | 0.57% | -38.0% |
Q1 2022 | $9,516,000 | -31.4% | 7,929,918 | 0.0% | 0.92% | -16.0% |
Q4 2021 | $13,877,000 | -26.8% | 7,929,918 | 0.0% | 1.10% | -6.5% |
Q3 2021 | $18,953,000 | -34.7% | 7,929,918 | 0.0% | 1.18% | -38.2% |
Q2 2021 | $29,024,000 | -33.8% | 7,929,918 | 0.0% | 1.90% | -23.4% |
Q1 2021 | $43,852,000 | -18.1% | 7,929,918 | +12.3% | 2.48% | -26.1% |
Q4 2020 | $53,517,000 | +581.1% | 7,060,353 | +82.4% | 3.36% | +359.0% |
Q3 2020 | $7,858,000 | -30.7% | 3,871,164 | 0.0% | 0.73% | -38.4% |
Q2 2020 | $11,343,000 | +22.6% | 3,871,164 | 0.0% | 1.19% | -24.1% |
Q1 2020 | $9,252,000 | -46.3% | 3,871,164 | 0.0% | 1.56% | -39.1% |
Q4 2019 | $17,227,000 | -57.0% | 3,871,164 | 0.0% | 2.57% | -75.1% |
Q3 2019 | $40,028,000 | +249.9% | 3,871,164 | +94.6% | 10.31% | +77.4% |
Q2 2019 | $11,439,000 | -37.5% | 1,989,444 | 0.0% | 5.81% | -20.6% |
Q1 2019 | $18,303,000 | -65.7% | 1,989,444 | 0.0% | 7.32% | -59.8% |
Q4 2018 | $53,317,000 | -43.2% | 1,989,444 | 0.0% | 18.22% | -14.5% |
Q3 2018 | $93,862,000 | +32.4% | 1,989,444 | 0.0% | 21.30% | -4.1% |
Q2 2018 | $70,884,000 | +375.1% | 1,989,444 | 0.0% | 22.21% | +152.5% |
Q1 2018 | $14,921,000 | – | 1,989,444 | – | 8.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,989,444 | $53,317,000 | 18.22% |
Boxer Capital, LLC | 3,498,272 | $93,754,000 | 11.58% |
RA Capital Management | 2,689,444 | $72,077,000 | 4.20% |
Perceptive Advisors | 3,927,222 | $105,249,000 | 4.01% |
EcoR1 Capital, LLC | 867,246 | $23,242,000 | 2.33% |
EMORY UNIVERSITY | 68,714 | $1,842,000 | 1.45% |
Cormorant Asset Management, LP | 652,987 | $17,500,000 | 1.42% |
PFM Health Sciences, LP | 1,335,080 | $35,780,000 | 0.95% |
Foresite Capital Management III, LLC | 98,942 | $2,652,000 | 0.87% |
ARMISTICE CAPITAL, LLC | 332,000 | $8,898,000 | 0.67% |